Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722008 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
Site LicenseAdd to Basket
Hard CopyAdd to Basket



RNAi Therapeutics 2008 Market Report
Select Biosciences Ltd, Nov 2007, Pages: 171


  Description  
  Table of Contents  
  Companies Mentioned  
    
    
   
 Enquire before Buying  
 Send to a Friend  

This is the latest RNAi-based Therapeutics Market. This report presents an up-to-date thorough analysis of the RNAi therapeutics landscape based upon our continuing coverage of this dynamic marketplace. This report presents an exhaustive analysis of all the therapeutics areas where research efforts using RNAi-based therapeutics are being focused: From Research/Pre-Clinical through Phase III Clinical Trials. Our proprietary market survey addresses druggability trends, drug target classes (where RNAi therapeutics will impact) and different therapeutic areas in terms of challenges/opportunities/quantitative industry metrics—this highly valuable dataset is based on an extensive market analysis.

An extensive analysis of the Intellectual Property (IP) landscape in RNAi therapeutics space, RNAi technology trends, and relevant company profiles make this report a complete and timely industry analysis.

Topics Covered in this Report

-Opportunities and challenges in the RNAi therapeutics space
-Therapeutics areas impacted by RNAi therapeutics: Timeline for impact, top-most challenge in each therapeutic area
-Different target classes and their amenability to targeting using RNAi therapeutics
-Top-most drug target class for RNAi therapeutics
-Delivery approach by therapeutic area
-Factors that determine whether a given target will be druggable via RNAi-based therapeutics
-Opportunities for vendors in the space
-Research/Pre-Clinical, Phase I, Phase II, and Phase III RNAi therapeutics Clinical Trials: Details by company, molecular target, therapeutic/disease area, partnership[s]
-Technology trends in the RNAi space
-Intellectual property (IP) in the RNAi therapeutics space: Landscape and discussion of the various key patents
-Relevant company profiles: Partnerships, therapeutics/trials pipeline

Product samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought

RNAi 2008

Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities

The Future of RNAi Therapeutics: Drug Pipelines and Prospects

RNAi - Technologies, Markets and Companies

Outlook for RNAi, 2007: siRNA and miRNA in Biology, Diagnostics and Therapeutics

The Outlook For RNAi: Accelerating Drug Discovery and the Development of RNAi Therapeutics

Realizing the Promise of Therapeutic RNAi: Emerging Strategies for RNAi Delivery

RNAi/MicroRNA Market Report 2007

The Exploding RNAi Market & Future Direction Translating the Genome into a Large Market by 2009

RNAi: Broad Application, Expansive Opportunity, 2nd Edition

U.S. RNAi Markets

Advances in RNAi--A Global Technology Assessment (Technical Insights)



Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds